Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There is a lack of data to determine the comparative advantages of 5% hypertonic saline and 3% hypertonic saline over the other. Hence, the current study was planned to determine their comparative effectiveness by comparing the change in means of central corneal thickness in the groups receiving 3% hypertonic saline and 5% hypertonic saline eyedrops developing post-phacoemulsification corneal edema.
Although corneal edema and the associated visual impairment after cataract surgery are temporary, it is still a reason for discomfort for the patient. It is therefore absolutely necessary that the patient be counselled regarding the risk of developing corneal edema after phacoemulsification. Several international studies have demonstrated the effectiveness of 5% hypertonic saline in improving visual acuity and reducing corneal thickness through clinical and pachymetric assessments. However, similar research has yet to be conducted in the Pakistani population. The findings of this study would add to the existing literature and also help clinicians to opt for the better choice of care in achieving patients' good outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group-A | Experimental | Patients received 5% hypertonic saline 2 hourly for the first 24 hours and then four times daily for the next 6 days. |
|
| Group-B | Experimental | Patients received 3% hypertonic saline 2 hourly for the first 24 hours and then four times daily for the next 6 days. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 5% Hypertonic Saline | Drug | Patients received 5% hypertonic saline 2 hourly for the first 24 hours and then four times daily for the next 6 days. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Central corneal thickness | Post-treatment central corneal thickness in micrometer was compared between the two groups. | 6 days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anum Amin | Pakistan Air Force (PAF) hospital/Fazaia Post Graduate Medical Institute, Islamabad | Principal Investigator |
| Muhammad Azam, FCPS | Pakistan Air Force (PAF) hospital/Fazaia Post Graduate Medical Institute, Islamabad | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pakistan Air Force (PAF) hospital/Fazaia Post Graduate Medical Institute | Islamabad | Punjab Province | 44000 | Pakistan |
Data can be shared on a reasonable request.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015715 | Corneal Edema |
| ID | Term |
|---|---|
| D003316 | Corneal Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D012462 | Saline Solution, Hypertonic |
| ID | Term |
|---|---|
| D006982 | Hypertonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3% Hypertonic Saline | Drug | Patients received 3% hypertonic saline 2 hourly for the first 24 hours and then four times daily for the next 6 days. |
|